These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37143958)

  • 1. Effectiveness of Polyclonal Antibody Immunoconjugate Treatment with Propamidine Isethionate for Amoebic Keratitis in Golden Hamsters.
    Ávila-Blanco ME; Aguilera-Martínez SL; Ventura-Juarez J; Pérez-Serrano J; Casillas-Casillas E; Barba-Gallardo LF
    J Parasitol Res; 2023; 2023():3713368. PubMed ID: 37143958
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of intrastromal injection of polyhexamethylene biguanide and propamidine isethionate in a rabbit model.
    Lim CC; Peng IC; Huang YH
    J Adv Res; 2020 Mar; 22():1-6. PubMed ID: 31956437
    [No Abstract]   [Full Text] [Related]  

  • 3. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
    Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
    Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro amoebicidal activity of propamidine and pentamidine isethionate against Acanthamoeba species and toxicity to corneal tissues.
    Alizadeh H; Silvany RE; Meyer DR; Dougherty JM; McCulley JP
    Cornea; 1997 Jan; 16(1):94-100. PubMed ID: 8985640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silver Nanoparticles as a Novel Potential Preventive Agent against Acanthamoeba Keratitis.
    Hendiger EB; Padzik M; Sifaoui I; Reyes-Batlle M; López-Arencibia A; Rizo-Liendo A; Bethencourt-Estrella CJ; Nicolás-Hernández DS; Chiboub O; Rodríguez-Expósito RL; Grodzik M; Pietruczuk-Padzik A; Stępień K; Olędzka G; Chomicz L; Piñero JE; Lorenzo-Morales J
    Pathogens; 2020 May; 9(5):. PubMed ID: 32380785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga.
    Perrine D; Chenu JP; Georges P; Lancelot JC; Saturnino C; Robba M
    Antimicrob Agents Chemother; 1995 Feb; 39(2):339-42. PubMed ID: 7726493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites.
    Kashiwabuchi RT; Carvalho FR; Khan YA; de Freitas D; Foronda AS; Hirai FE; Campos MS; McDonnell PJ
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9333-8. PubMed ID: 22058341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presumed late recurrence of Acanthamoeba keratitis exacerbated by exposure to topical corticosteroids.
    Patel DV; McGhee CNj
    Oman J Ophthalmol; 2013 Sep; 6(Suppl 1):S40-2. PubMed ID: 24391372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the management of Acanthamoeba keratitis: A review of the literature and synthesized algorithmic approach.
    Kaufman AR; Tu EY
    Ocul Surf; 2022 Jul; 25():26-36. PubMed ID: 35462076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].
    Walochnik J; Duchêne M; Eibl H; Aspöck H
    Wien Klin Wochenschr; 2003; 115 Suppl 3():10-7. PubMed ID: 15508774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of the Current Research Trends in the Application of Medicinal Plants as a Source for Novel Therapeutic Agents Against
    Niyyati M; Dodangeh S; Lorenzo-Morales J
    Iran J Pharm Res; 2016; 15(4):893-900. PubMed ID: 28243287
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.
    Duguid IG; Dart JK; Morlet N; Allan BD; Matheson M; Ficker L; Tuft S
    Ophthalmology; 1997 Oct; 104(10):1587-92. PubMed ID: 9331195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis.
    Musayeva A; Riedl JC; Schuster AK; Wasielica-Poslednik J; Pfeiffer N; Gericke A
    Cornea; 2020 Aug; 39(8):986-990. PubMed ID: 32243421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group.
    Hargrave SL; McCulley JP; Husseini Z
    Ophthalmology; 1999 May; 106(5):952-7. PubMed ID: 10328395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ethanol pretreatment in
    Lin IH; Tseng SH; Huang FC; Huang YH
    Infect Drug Resist; 2018; 11():937-943. PubMed ID: 30013376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of early Acanthamoeba keratitis with alcohol-assisted epithelial debridement.
    Li ML; Shih MH; Huang FC; Tseng SH; Chen CC
    Cornea; 2012 Apr; 31(4):442-6. PubMed ID: 22236786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Effect of Pitavastatin and Its Synergistic Activity with Isavuconazole against
    Hahn HJ; Escrig JI; Shing B; Debnath A
    Pathogens; 2020 Aug; 9(9):. PubMed ID: 32825652
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Off-Label Anti-Amoebic Agents to Suppress Trophozoite Formation of
    Muthukumar V; Shi L; Chai N; Langenbucher A; Becker SL; Seitz B; Orosz E; Stachon T; Kiderlen AF; Bischoff M; Szentmáry N
    Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36014060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.